216 related articles for article (PubMed ID: 11462207)
1. Bacteremia caused by Capnocytophaga species in patients with neutropenia and cancer: results of a multicenter study.
Martino R; Rámila E; Capdevila JA; Planes A; Rovira M; Ortega Md ; Plumé G; Gómez L; Sierra J
Clin Infect Dis; 2001 Aug; 33(4):E20-2. PubMed ID: 11462207
[TBL] [Abstract][Full Text] [Related]
2. Bacteremia due to Capnocytophaga species in patients with neutropenia: high frequency of beta-lactamase-producing strains.
Maury S; Leblanc T; Rousselot P; Legrand P; Arlet G; Cordonnier C
Clin Infect Dis; 1999 May; 28(5):1172-4. PubMed ID: 10452663
[No Abstract] [Full Text] [Related]
3. [Capnocytophaga spp. bacteremia in compromised patients].
Ramos JM; Pacho E; Bernacer M; Fernández-Roblas R; Soto C; Soriano F
Enferm Infecc Microbiol Clin; 1993 Apr; 11(4):206-9. PubMed ID: 8512974
[TBL] [Abstract][Full Text] [Related]
4. Bacteremia due to Stenotrophomonas maltophilia in patients with hematologic malignancies.
Micozzi A; Venditti M; Monaco M; Friedrich A; Taglietti F; Santilli S; Martino P
Clin Infect Dis; 2000 Sep; 31(3):705-11. PubMed ID: 11017819
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology of bloodstream infections in patients with haematological malignancies with and without neutropenia.
Chen CY; Tsay W; Tang JL; Tien HF; Chen YC; Chang SC; Hsueh PR
Epidemiol Infect; 2010 Jul; 138(7):1044-51. PubMed ID: 19941686
[TBL] [Abstract][Full Text] [Related]
6. Capnocytophaga bacteremia: clinical features of patients and antimicrobial susceptibility of isolates.
Lin RD; Hsueh PR; Chang SC; Luh KT
J Formos Med Assoc; 1998 Jan; 97(1):44-8. PubMed ID: 9481064
[TBL] [Abstract][Full Text] [Related]
7. [Bacteremia caused by Capnocytophaga ochracea: apropos of 2 cases].
Viudes A; Orero A; Larrea L; Pérez Bellés C; Pérez de Léon A; Pérez Silvert M; Gobernado M
Enferm Infecc Microbiol Clin; 1997; 15(6):338-9. PubMed ID: 9376412
[No Abstract] [Full Text] [Related]
8. Capnocytophaga gingivalis bacteremia detected only on quantitative blood cultures in a child with leukemia.
Mantadakis E; Danilatou V; Christidou A; Stiakaki E; Kalmanti M
Pediatr Infect Dis J; 2003 Feb; 22(2):202-4. PubMed ID: 12613461
[TBL] [Abstract][Full Text] [Related]
9. Gram-negative organisms predominate in Hickman line-related infections in non-neutropenic patients with hematological malignancies.
Chee L; Brown M; Sasadeusz J; MacGregor L; Grigg AP
J Infect; 2008 Apr; 56(4):227-33. PubMed ID: 18342947
[TBL] [Abstract][Full Text] [Related]
10. Abiotrophia bacteremia in a patient with neutropenic fever and antimicrobial susceptibility testing of Abiotrophia isolates.
Murray CK; Walter EA; Crawford S; McElmeel ML; Jorgensen JH
Clin Infect Dis; 2001 May; 32(10):E140-2. PubMed ID: 11317266
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of moxifloxacin against Stenotrophomonas maltophilia blood isolates from patients with hematologic malignancies.
Venditti M; Monaco M; Micozzi A; Tarasi A; Friedrich A; Martino P
Clin Microbiol Infect; 2001 Jan; 7(1):37-9. PubMed ID: 11284945
[No Abstract] [Full Text] [Related]
12. [Capnocytophaga spp. bacteremia in neutropenic patients].
Cobo Martínez F; Sanbonmatsu Gámez S; Manchado Mañas P; Cuesta Casas MA; Carabantes Ocón FJ
Rev Clin Esp; 2002 Jul; 202(7):413-4. PubMed ID: 12139833
[No Abstract] [Full Text] [Related]
13. Clinical and microbiological characteristics of Rhizobium radiobacter infections.
Lai CC; Teng LJ; Hsueh PR; Yuan A; Tsai KC; Tang JL; Tien HF
Clin Infect Dis; 2004 Jan; 38(1):149-53. PubMed ID: 14679463
[TBL] [Abstract][Full Text] [Related]
14. Five years of nosocomial Gram-negative bacteremia in a general intensive care unit: epidemiology, antimicrobial susceptibility patterns, and outcomes.
Sligl W; Taylor G; Brindley PG
Int J Infect Dis; 2006 Jul; 10(4):320-5. PubMed ID: 16460982
[TBL] [Abstract][Full Text] [Related]
15. [Bacteremia due to Capnocytophaga spp.: two cases].
García J; Lizasoain M; Lahuerta JJ; Sanz F
Enferm Infecc Microbiol Clin; 2003 Mar; 21(3):168-9. PubMed ID: 12586027
[No Abstract] [Full Text] [Related]
16. [Bacteremia due to Capnocytophaga species during chemotherapy-induced neutropenia in patients with hematological malignancies].
Murakami K; Mori T; Kato J; Shimizu T; Kohashi S; Sakurai M; Sugita K; Hasegawa N; Murata M; Okamoto S
Rinsho Ketsueki; 2017; 58(3):210-215. PubMed ID: 28381687
[TBL] [Abstract][Full Text] [Related]
17. Clinical guidelines for the management of neutropenic patients with unexplained fever in Japan: validation by the Japan Febrile Neutropenia Study Group.
Tamura K
Int J Antimicrob Agents; 2005 Dec; 26 Suppl 2():S123-7; discussion S133-40. PubMed ID: 16249072
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial treatment of Capnocytophaga infections.
Jolivet-Gougeon A; Sixou JL; Tamanai-Shacoori Z; Bonnaure-Mallet M
Int J Antimicrob Agents; 2007 Apr; 29(4):367-73. PubMed ID: 17250994
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with mortality in bacteremic patients with hematologic malignancies.
Tumbarello M; Spanu T; Caira M; Trecarichi EM; Laurenti L; Montuori E; Fianchi L; Leone F; Fadda G; Cauda R; Pagano L
Diagn Microbiol Infect Dis; 2009 Jul; 64(3):320-6. PubMed ID: 19345033
[TBL] [Abstract][Full Text] [Related]
20. Microbiological data for patients with febrile neutropenia.
Kanamaru A; Tatsumi Y
Clin Infect Dis; 2004 Jul; 39 Suppl 1():S7-S10. PubMed ID: 15250014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
